Edgewise Therapeutics股价飙升,第二季度亏损收窄,优于预期

英为财情
Aug 08, 2025

Investing.com -- 专注于肌肉疾病的生物制药公司Edgewise Therapeutics, Inc. (NASDAQ:EWTX)报告2025年第二季度亏损低于预期,使其股价上涨6%,投资者对公司的财务表现和临床进展反应积极。 该公司公布季度亏损为每股0.34美元,明显好于分析师预期的每股亏损0.42美元。截至2025年6月30日,Edgewise季末现金状况强劲,约有5.94亿美元...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10